Merus N.V. Files 2024 Annual Report Amendment
| Field | Detail |
|---|---|
| Company | Merus N.V. |
| Form Type | 10-K/A |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceutical
TL;DR
Merus N.V. amended its 2024 10-K, check for updated financials and disclosures.
AI Summary
Merus N.V. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, dated April 7, 2025, provides updated information for the company, which is incorporated in The Netherlands and operates in the Pharmaceutical Preparations sector. The company's principal executive offices are located in Utrecht, The Netherlands.
Why It Matters
This amendment to the annual report provides updated financial and operational information for Merus N.V., which is crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This filing is an amendment to a standard annual report and does not appear to contain significant new negative information.
Key Numbers
- 001-37773 — SEC File Number (Identifies the company's filings with the SEC)
- 2024-12-31 — Fiscal Year End (The period covered by the annual report)
Key Players & Entities
- Merus N.V. (company) — Registrant
- 2024 (date) — Fiscal year end
- April 7, 2025 (date) — Filing date
- The Netherlands (location) — Jurisdiction of incorporation
- Utrecht (location) — Business address city
FAQ
What specific information is being amended in this 10-K/A filing?
The filing is an amendment to the annual report for the fiscal year ended December 31, 2024, but the specific details of the amendments are not provided in the header information.
When was the original 10-K filed?
The header information does not explicitly state the original filing date, only the amendment date of April 7, 2025.
What is Merus N.V.'s primary business sector?
Merus N.V. is classified under Pharmaceutical Preparations [2834].
Where are Merus N.V.'s principal executive offices located?
Merus N.V.'s principal executive offices are located at Yalelaan 62, 3584 CM Utrecht, The Netherlands.
What is the company's Central Index Key (CIK)?
Merus N.V.'s Central Index Key is 0001651311.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 7, 2025 regarding Merus N.V..